-
Patent Agency Ranking
公开(公告)号：US20070015818A1
公开(公告)日：2007-01-18
申请号：US11480586
申请日：2006-07-05
Applicant: Deborah Bertenshaw , Daniel Getman , Robert Heintz , John Talley , Kathryn Reed , Robert Chrusciel , Michael Clare
Inventor： Deborah Bertenshaw , Daniel Getman , Robert Heintz , John Talley , Kathryn Reed , Robert Chrusciel , Michael Clare
IPC: A61K31/382 , A61K31/381 , C07D335/02 , C07D333/20
CPC classification number: C07D207/30 , C07C213/10 , C07C215/18 , C07C215/26 , C07C215/28 , C07C271/20 , C07C275/24 , C07D211/06 , C07D211/26
Abstract: The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
Abstract translation: 本发明涉及含环状砜部分的羟乙基胺蛋白酶抑制剂化合物及其用途的药物或方法，特别是作为HIV蛋白酶的抑制剂。
-
2.发明申请Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors 失效可用作逆转录病毒蛋白酶抑制剂的α-氨基酸和β-氨基酸羟乙基氨基磺酰胺公开(公告)号：US20050267171A1
公开(公告)日：2005-12-01
申请号：US11110943
申请日：2005-04-21
Applicant: Michael Vazquez , Richard Mueller , John Talley , Daniel Getman , Gary DeCrescenzo , John Freskos , Deborah Bertenshaw , Robert Heintz
Inventor： Michael Vazquez , Richard Mueller , John Talley , Daniel Getman , Gary DeCrescenzo , John Freskos , Deborah Bertenshaw , Robert Heintz
IPC: A61K31/16 , A61K31/18 , A61K31/44 , A61K38/00 , C07C311/05 , C07C311/18 , C07C311/20 , C07C311/29 , C07C311/41 , C07C311/46 , C07C317/10 , C07C317/14 , C07C317/44 , C07C323/67 , C07C327/42 , C07D209/08 , C07D213/24 , C07D213/30 , C07D213/64 , C07D213/73 , C07D213/81 , C07D213/82 , C07D213/89 , C07D215/48 , C07D233/54 , C07D239/26 , C07D277/24 , C07D277/82 , C07D307/20 , C07D307/42 , C07D307/79 , C07D317/62 , C07D333/34 , C07D405/12 , C07D417/12 , C07K5/06 , C07K5/078
CPC classification number: C07C311/05 , A61K38/00 , C07C311/11 , C07C311/13 , C07C311/14 , C07C311/18 , C07C311/20 , C07C311/24 , C07C311/29 , C07C311/32 , C07C311/41 , C07C311/46 , C07C317/04 , C07C317/10 , C07C317/14 , C07C317/28 , C07C317/44 , C07C323/49 , C07C323/67 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07D209/08 , C07D213/30 , C07D213/42 , C07D213/64 , C07D213/73 , C07D213/74 , C07D213/81 , C07D213/82 , C07D213/89 , C07D215/48 , C07D217/26 , C07D233/64 , C07D239/26 , C07D241/18 , C07D241/44 , C07D261/08 , C07D263/34 , C07D263/56 , C07D277/24 , C07D277/62 , C07D277/82 , C07D307/20 , C07D307/42 , C07D307/45 , C07D307/79 , C07D307/85 , C07D317/62 , C07D333/32 , C07D333/34 , C07D333/48 , C07D401/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07D493/04 , C07K5/06026 , C07K5/06139
Abstract: α- and β-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Abstract translation: α-和β-氨基酸羟乙基氨基磺酰胺化合物作为逆转录病毒蛋白酶抑制剂是有效的，特别是作为HIV蛋白酶的抑制剂。
-
3.发明申请alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors 失效可用作逆转录病毒蛋白酶抑制剂的α-和β-氨基酸羟乙基氨基磺酰胺公开(公告)号：US20060276493A1
公开(公告)日：2006-12-07
申请号：US11433797
申请日：2006-05-15
Applicant: Michael Vasquez , Richard Mueller , John Talley , Daniel Getman , Gary DeCrescenzo , John Freskos , Deborah Bertenshaw , Robert Heintz
Inventor： Michael Vasquez , Richard Mueller , John Talley , Daniel Getman , Gary DeCrescenzo , John Freskos , Deborah Bertenshaw , Robert Heintz
IPC: A61K31/513 , A61K31/4412 , A61K31/4706 , A61K31/426 , A61K31/421 , A61K31/381 , A61K31/34 , A61K31/18
CPC classification number: C07C311/05 , A61K38/00 , C07C311/11 , C07C311/13 , C07C311/14 , C07C311/18 , C07C311/20 , C07C311/24 , C07C311/29 , C07C311/32 , C07C311/41 , C07C311/46 , C07C317/04 , C07C317/10 , C07C317/14 , C07C317/28 , C07C317/44 , C07C323/49 , C07C323/67 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07D209/08 , C07D213/30 , C07D213/42 , C07D213/64 , C07D213/73 , C07D213/74 , C07D213/81 , C07D213/82 , C07D213/89 , C07D215/48 , C07D217/26 , C07D233/64 , C07D239/26 , C07D241/18 , C07D241/44 , C07D261/08 , C07D263/34 , C07D263/56 , C07D277/24 , C07D277/62 , C07D277/82 , C07D307/20 , C07D307/42 , C07D307/45 , C07D307/79 , C07D307/85 , C07D317/62 , C07D333/32 , C07D333/34 , C07D333/48 , C07D401/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07D493/04 , C07K5/06026 , C07K5/06139
Abstract: α- and β-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as-inhibitors of HIV protease.
Abstract translation: α-和β-氨基酸羟乙基氨基磺酰胺化合物作为逆转录病毒蛋白酶抑制剂，特别是HIV蛋白酶的抑制剂是有效的。
-
公开(公告)号：US20050119257A1
公开(公告)日：2005-06-02
申请号：US10932331
申请日：2004-09-02
Applicant: Deborah Bertenshaw , Daniel Getman , Robert Heintz , John Talley , Kathryn Reed , Robert Chrusciel , Michael Clare
Inventor： Deborah Bertenshaw , Daniel Getman , Robert Heintz , John Talley , Kathryn Reed , Robert Chrusciel , Michael Clare
IPC: A61K31/38 , A61K31/381 , A61K31/382 , A61K31/415 , A61K31/425 , A61K31/4433 , A61K31/445 , A61K31/54 , A61P31/12 , A61P43/00 , C07D279/12 , C07D283/00 , C07D333/48 , C07D335/02 , C07D409/12 , C07D417/12 , C07D521/00 , C07D417/02 , C07D49/02
CPC classification number: C07D333/48 , C07D231/12 , C07D233/56 , C07D249/08 , C07D279/12 , C07D335/02 , C07D409/12
Abstract: The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
-
5.发明申请Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors 失效可用作逆转录病毒蛋白酶抑制剂的α-氨基酸和β-氨基酸羟乙基氨基磺酰胺公开(公告)号：US20070078173A1
公开(公告)日：2007-04-05
申请号：US11526101
申请日：2006-09-25
Applicant: Michael Vazquez , Richard Mueller , John Talley , Daniel Getman , Gary DeCrescenzo , John Freskos , Robert Heintz , Deborah Bertenshaw
Inventor： Michael Vazquez , Richard Mueller , John Talley , Daniel Getman , Gary DeCrescenzo , John Freskos , Robert Heintz , Deborah Bertenshaw
IPC: A61K31/44 , A61K31/18 , C07D213/24 , C07C311/45
CPC classification number: C07C311/05 , A61K38/00 , C07C311/11 , C07C311/13 , C07C311/14 , C07C311/18 , C07C311/20 , C07C311/24 , C07C311/29 , C07C311/32 , C07C311/41 , C07C311/46 , C07C317/04 , C07C317/10 , C07C317/14 , C07C317/28 , C07C317/44 , C07C323/49 , C07C323/67 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07D209/08 , C07D213/30 , C07D213/64 , C07D213/73 , C07D213/81 , C07D213/82 , C07D213/89 , C07D215/48 , C07D233/64 , C07D239/26 , C07D277/24 , C07D277/82 , C07D307/20 , C07D307/42 , C07D307/79 , C07D317/62 , C07D333/34 , C07D405/12 , C07D417/12 , C07K5/06026 , C07K5/06139
Abstract: α- and β-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Abstract translation: α-和β-氨基酸羟乙基氨基磺酰胺化合物作为逆转录病毒蛋白酶抑制剂是有效的，特别是作为HIV蛋白酶的抑制剂。
-
-
-
-
Search Results
5
records
(took 0.014 seconds)
